Why are drug prices so high? Investigating th...

What good is a vaccine people don't trust? Immunologist and TED Fellow Kizzmekia Corbett co-developed the first COVID-19 vaccine to enter clinical trials — but she'll tell you that making the vaccine was never the hardest part. The real obstacle is the gap between scientists and ...  Show more

Trigger warning - this episode contains mention of suicide and severe depression.For years, the warning has been: smartphones are destroying a generation. But developmental psychologist Candice Odgers says that decades of data on teens tells a different story — violence, alcohol ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...